0 items USD 0.00Search
- Did you mean
- margin zoho lymphoma
Your search for "Marginal zone lymphoma" gave back 80005 results.
The global Lymphoma Treatment Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Surgery for T-cell Lymphoma market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a...
Catalog:
LPI
July 2023
Price: USD 3,660.00
The global Mantle Cell Lymphoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Indolent Lymphoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Hodgkin Lymphoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Surgery for T-cell Lymphoma market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Non-Hodgkin Lymphoma Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Non-Hodgkin lymphoma (NHL) is an umbrella term for a group of independent diseases with strong heterogeneity The global Adult Non-Hodgkin Lymphoma...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Mantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Surgery for T-cell Lymphoma market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Adult Non-Hodgkin Lymphoma Treatment market size is projected to grow from US$ 7434.7 million in 2022 to US$ 13340 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The characterization of anaplastic lymphoma kinase (ALK) gene and their role in the development and progression of ALK positive cancer has...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Small Lymphocytic Lymphoma Therapy Market The global Small Lymphocytic Lymphoma Therapy market is projected to...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
